The Effect of Age and NT-proBNP on the Association of Central Obesity with 6-Years Cardiovascular Mortality of Middle-Aged and Elderly Diabetic People: The Population-Based Casale Monferrato Study
Background Among people with type 2 diabetes the relationship between central obesity and cardiovascular mortality has not been definitely assessed. Moreover, NT-proBNP is negatively associated with central obesity, but no study has examined their combined effect on survival. We have examined these issues in a well-characterized population-based cohort. Methods and Findings Survival data of 2272 diabetic people recruited in 2000 who had no other chronic disease have been updated to 31 December 2006. NT-proBNP was measured in a subgroup of 1690 patients. Cox proportional hazards modeling was employed to estimate the independent associations between cardiovascular and all-cause mortality and waist circumference. Mean age was 67.9 years, 49.3% were men. Both age and NT-proBNP were negatively correlated with waist circumference (r = ？0.11, p<0.001 and r = ？0.07, p = 0.002). Out of 2272 subjects, 520 deaths (221 for CV mortality) occurred during a median follow-up of 5.4 years. Central obesity was not associated with CV mortality (hazard ratio, HR, adjusted for age, sex, diabetes duration, 1.14, 95% CI 0.86–1.52). NTproBNP was a negative confounder and age a strong modifier of this relationship (p for interaction<0.001): age<70 years, fully adjusted model HR = 3.52 (1.17–10.57) and age ≥70 years, HR = 0.80 (0.46–1.40). Respective HRs for all-cause mortality were 1.86 (1.03–3.32) and 0.73 (0.51–1.04). Conclusions In diabetic people aged 70 years and lower, central obesity was independently associated with increased cardiovascular mortality, independently of the negative effect of NT-proBNP. In contrast, no effect on 6-years survival was evident in diabetic people who have yet survived up to 70 years.
References
[1]
Lawlor DA, Hart CL, Hole DJ, Davey Smith G (2006) Reverse causality and confounding and the associations of overweight and obesity with mortality. Obesity 14: 2294–304. doi: 10.1038/oby.2006.269
[2]
Chrysant SG, Chrysant GS (2013) New insights into the true nature of the obesity paradox and the lower cardiovascular risk. J Am Soc Hypertens 7: 85–94. doi: 10.1016/j.jash.2012.11.008
[3]
Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, et al. (2006) Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355: 763–78. doi: 10.1056/nejmoa055643
[4]
Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW (1999) Body-mass index and mortality in a prospective cohort of U.S. Adults. N Eng J Med 341: 1097–1105. doi: 10.1056/nejm199910073411501
[5]
Breeze E, Clarke R, Shipley MJ, Marmot MG, Fletcher A (2006) Cause-specific mortality in old age in relation to body mass index in middle age and in old age: follow-up of the Whitehall cohort of male civil servants. Int J Epidemiol 35: 169–78. doi: 10.1093/ije/dyi212
[6]
Price GM, Uauy R, Breeze E, Bulpitt CJ, Fletcher AE (2006) Weight, shape, and mortality risk in older persons: elevated waist-hip ratio, not high body mass index, is associated with a greater risk of death. Am J Clin Nutr 84: 449–60.
[7]
Corrada MM, Kawas CH, Mozaffar F, Paganini-Hill A (2006) Association of body mass index and weight change with all-cause mortality in the elderly. Am J Epidemiol 163: 938–49. doi: 10.1093/aje/kwj114
[8]
Eeg-Olofsson K, Cederholm J, Nilsson PM, Zethelius B, Nunez L, et al. (2009) Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients. Diabetologia 52: 65–73. doi: 10.1007/s00125-008-1190-x
[9]
Katzmarzyk PT, Hu G, Cefalu WT, Mire E, Bouchard C (2013) The Importance of Waist Circumference and BMI for Mortality Risk in Diabetic Adults. Diabetes Care 36: 3128–30. doi: 10.2337/dc13-0219
[10]
Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, et al. (2004) Impact of obesity on plasma natriuretic peptide levels. Circulation 109: 594–600. doi: 10.1161/01.cir.0000112582.16683.ea
[11]
Park SJ, Cho KI, Jung SJ, Choi SW, Choi JW, et al. (2009) N-terminal pro-B-type natriuretic peptide in overweight and obese patients with and without diabetes: An analysis based on BMI and left ventricular geometry. Korean Circ J 39: 538–544. doi: 10.4070/kcj.2009.39.12.538
[12]
Bruno G, Landi A, Barutta F, Ghezzo G, Baldin C, et al. (2013) NH2-terminal pro-brain natriuretic peptide is a stronger predictor of cardiovascular mortality than C-reactive protein and albumin excretion rate in elderly patients with type 2 diabetes: The Casale Monferrato population- based study. Diabetes Care 36: 2677–82. doi: 10.2337/dc13-0353
[13]
Tarnow L, Gall M-A, Hansen BV, Hovind P, Parving HH (2006) Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes. Diabetologia 49: 2256–2262. doi: 10.1007/s00125-006-0359-4
[14]
Cheng S, Fox CS, Larson MG, Massaro JM, McCabe EL, et al. (2011) Relation of visceral adiposity to circulating natriuretic peptides in ambulatory individuals. Am J Cardiol 108: 979–84. doi: 10.1016/j.amjcard.2011.05.033
[15]
Perotto M, Panero F, Gruden G, Fornengo P, Lorenzati B, et al. (2013) Obesity and mortality in type 2 diabetes: the Casale Monferrato Study. Acta Diabetologica 50: 563–568. doi: 10.1007/s00592-011-0338-1
[16]
Bruno G, Merletti F, Bargero G, Melis D, Masi I, et al. (2008) Changes over time in the prevalence and quality of care of type 2 diabetes in Italy: the Casale Monferrato Surveys, 1988 and 2000. Nutr Metab Cardiovasc Dis 18: 39–45. doi: 10.1016/j.numecd.2006.08.007
[17]
Bruno G, Fornengo P, Novelli G, Panero F, Perotto M, et al. (2009) C-reactive protein and 5-years survival in type 2 diabetes: the Casale Monferrato Study. Diabetes 58: 926–933. doi: 10.2337/db08-0900
[18]
Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, et al. (2008) General and abdominal adiposity and risk of death in Europe. N Engl J Med 359: 2105–20. doi: 10.1056/nejmoa0801891
[19]
Zeller M, Steg PG, Ravisy J, Lorgis L, Laurent Y, et al. (2008) Relation between body mass index, waist circumference, and death after acute myocardial infarction. Circulation 118: 482–90. doi: 10.1161/circulationaha.107.753483
[20]
Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB (2008) Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation 117: 1658–67. doi: 10.1161/circulationaha.107.739714
[21]
Martin J, Bergeron S, Pibarot P, Bastien M, Biertho L, et al. (2013) Impact of bariatric surgery on N-terminal fragment of the prohormone brain natriuretic peptide and left ventricular diastolic function. Can J Cardiol 29: 969–75. doi: 10.1016/j.cjca.2012.11.010
[22]
Kim BH, Kim IJ, Cho KI, Kim SM, Lee HG, et al. (2010) The influence of diabetes on the relationship between N-terminal pro-B-type natriuretic peptide and body mass index. J Int Med Res 38: 1737–1748. doi: 10.1177/147323001003800519
[23]
Kalra PR, Tigas S (2002) Regulation of lipolysis: Natriuretic peptides and the development of cachexia. Int J Cardiol 85: 125–132. doi: 10.1016/s0167-5273(02)00241-3
[24]
Yamada-Goto N, Katsuura G, Ebihara K, Inuzuka M, Ochi Y, et al. (2013) Intracerebroventricular administration of C-type natriuretic peptide suppresses food intake via activation of the melanocortin system in mice. Diabetes 62: 1500–4. doi: 10.2337/db12-0718
[25]
Moro C, Lafontan M (2013) Natriuretic peptides and cGMP signaling control of energy homeostasis. Am J Physiol Heart Circ Physiol. 304: H358–68. doi: 10.1152/ajpheart.00704.2012
[26]
Kyrou I, Tsigos C (2009) Obesity in the elderly diabetic patient. Is weight loss beneficial? No. Diabetes Care 32 (suppl (2)) S403–S409. doi: 10.2337/dc09-s348
[27]
Ko KP, Oh DK, Min H, Kim CS, Park JK, et al. (2012) Prospective study of optimal obesity index cutoffs for predicting development of multiple metabolic risk factors: the Korean genome and epidemiology study. J Epidemiol 22: 433–9. doi: 10.2188/jea.je20110164
[28]
Nakamura K, Nanri H, Hara M, Higaki Y, Imaizumi T, et al. (2011) Optimal cutoff values of waist circumference and the discriminatory performance of other anthropometric indices to detect the clustering of cardiovascular risk factors for metabolic syndrome in Japanese men and women. Environ Health Prev Med16: 52–60. doi: 10.1007/s12199-010-0165-y
